-
1
-
-
70350161415
-
The role of lithium in modulation of brain genes: Relevance for aetiology and treatment of bipolar disorder
-
Fatemi SH, Reutiman TJ, Folsom TD. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder. Biochem. Soc. Trans. 37(Pt 5), 1090-1095 (2009).
-
(2009)
Biochem. Soc. Trans.
, vol.37
, Issue.PART 5
, pp. 1090-1095
-
-
Fatemi, S.H.1
Reutiman, T.J.2
Folsom, T.D.3
-
2
-
-
4043169722
-
Bipolar disorder a seriously underestimated health burden
-
Angst J. Bipolar disorder a seriously underestimated health burden. Eur. Arch. Psychiatry Clin. Neurosci. 254, 59-60 (2004).
-
(2004)
Eur. Arch. Psychiatry Clin. Neurosci.
, vol.254
, pp. 59-60
-
-
Angst, J.1
-
3
-
-
77956913686
-
Duration of untreated illness and suicide in bipolar disorder: A naturalistic study
-
Altamura AC, DellOsso B, Berlin HA, Buoli M, Bassetti R, Mundo E. Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. Eur. Arch. Psychiatry Clin. Neurosci. 260(5), 385-391 (2010).
-
(2010)
Eur. Arch. Psychiatry Clin. Neurosci.
, vol.260
, Issue.5
, pp. 385-391
-
-
Altamura, A.C.1
Dellosso, B.2
Berlin, H.A.3
Buoli, M.4
Bassetti, R.5
Mundo, E.6
-
4
-
-
77957957255
-
Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication
-
Angst J, Cui L, Swendsen J et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am. J. Psychiatry 167(10), 1194-1201 (2010).
-
(2010)
Am. J. Psychiatry
, vol.167
, Issue.10
, pp. 1194-1201
-
-
Angst, J.1
Cui, L.2
Swendsen, J.3
-
5
-
-
34548387113
-
Is bipolar disorder overdiagnosed among patients with substance abuse?
-
Stewart C, El-Mallakh RS. Is bipolar disorder overdiagnosed among patients with substance abuse? Bipolar Disord. 9(6), 646-648 (2007).
-
(2007)
Bipolar Disord.
, vol.9
, Issue.6
, pp. 646-648
-
-
Stewart, C.1
El-Mallakh, R.S.2
-
6
-
-
57349190062
-
Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability
-
Goldberg JF, Garno JL, Callahan AM, Kearns DL, Kerner B, Ackerman SH. Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability. J. Clin. Psychiatry 69(11), 1751-1757 (2008).
-
(2008)
J. Clin. Psychiatry
, vol.69
, Issue.11
, pp. 1751-1757
-
-
Goldberg, J.F.1
Garno, J.L.2
Callahan, A.M.3
Kearns, D.L.4
Kerner, B.5
Ackerman, S.H.6
-
7
-
-
33748427055
-
Comorbidity and bipolar disorders
-
Kahn JP. Comorbidity and bipolar disorders. Encephale 32(Pt 2), S511-S514 (2006).
-
(2006)
Encephale
, vol.32
, Issue.PART 2
-
-
Kahn, J.P.1
-
8
-
-
78650395628
-
Patterns of Axis i comorbidity in relation to age in patients with bipolar disorder: A cross-sectional analysis
-
DOI:10.1016/j.jad.2010.10.008 Epub ahead of print
-
DellOsso B, Buoli M, Bortolussi S, Vecchi V, Camuri G, Altamura AC. Patterns of Axis I comorbidity in relation to age in patients with bipolar disorder: a cross-sectional analysis. J. Affect. Disord. DOI:10.1016/j.jad.2010. 10.008 (2010) (Epub ahead of print).
-
(2010)
J. Affect. Disord.
-
-
Dellosso, B.1
Buoli, M.2
Bortolussi, S.3
Vecchi, V.4
Camuri, G.5
Altamura, A.C.6
-
9
-
-
34247536530
-
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication
-
Merikangas KR, Akiskal HS, Angst J et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 64(5), 543-552 (2007).
-
(2007)
Arch. Gen. Psychiatry
, vol.64
, Issue.5
, pp. 543-552
-
-
Merikangas, K.R.1
Akiskal, H.S.2
Angst, J.3
-
10
-
-
75249093111
-
Suicide attempts in bipolar i and bipolar II disorder: A review and meta-analysis of the evidence
-
Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 12, 1-9 (2010).
-
(2010)
Bipolar Disord.
, vol.12
, pp. 1-9
-
-
Novick, D.M.1
Swartz, H.A.2
Frank, E.3
-
14
-
-
0030010429
-
Bipolar mood disorder: Practical strategies for acute and maintenance phase treatment
-
Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J. Clin Psychopharmacol. 16(2 Suppl. 1), S32-S47 (1996).
-
(1996)
J. Clin Psychopharmacol.
, vol.16
, Issue.2 SUPPL. 1
-
-
Sachs, G.S.1
-
15
-
-
1442289924
-
What is a mood stabilizer? An evidence-based response
-
Bauer MS, Mitchner L. What is a mood stabilizer? An evidence-based response. Am. J. Psychiatry 161(1), 3-18 (2004).
-
(2004)
Am. J. Psychiatry
, vol.161
, Issue.1
, pp. 3-18
-
-
Bauer, M.S.1
Mitchner, L.2
-
16
-
-
0036212604
-
What makes a drug a primary mood stabilizer? Mol
-
Keck PE Jr, McElroy SL, Richtand N, Tohen M. What makes a drug a primary mood stabilizer? Mol. Psychiatry 7(Suppl. 1), S8-S14 (2002).
-
(2002)
Psychiatry
, vol.7
, Issue.SUPPL. 1
-
-
Keck Jr., P.E.1
McElroy, S.L.2
Richtand, N.3
Tohen, M.4
-
17
-
-
0036179509
-
Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature
-
Ketter TA, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J. Clin Psychiatry 63, 146-151 (2002).
-
(2002)
J. Clin Psychiatry
, vol.63
, pp. 146-151
-
-
Ketter, T.A.1
Calabrese, J.R.2
-
18
-
-
0038642170
-
Selecting effective long-term treatment for bipolar patients: Monotherapy and combinations
-
Grof P. Selecting effective long-term treatment for bipolar patients: monotherapy and combinations. J. Clin. Psychiatry 64(Suppl. 5), 53-61 (2003).
-
(2003)
J. Clin. Psychiatry
, vol.64
, Issue.SUPPL. 5
, pp. 53-61
-
-
Grof, P.1
-
21
-
-
65249143218
-
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009
-
Yatham LN, Kennedy SH, Schaffer A et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 11(3), 225-255 (2009).
-
(2009)
Bipolar Disord.
, vol.11
, Issue.3
, pp. 225-255
-
-
Yatham, L.N.1
Kennedy, S.H.2
Schaffer, A.3
-
22
-
-
16544379823
-
On behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders the World Federation of Societies of Biological Psychiatry (WFSBP). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: Maintenance treatment
-
Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ; on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders The World Federation of Societies of Biological Psychiatry (WFSBP). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J. Biol. Psychiatry 5, 120-135 (2004).
-
(2004)
World J. Biol. Psychiatry
, vol.5
, pp. 120-135
-
-
Grunze, H.1
Kasper, S.2
Goodwin, G.3
Bowden, C.4
Möller, H.J.5
-
23
-
-
67650134119
-
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the treatment of acute mania
-
Grunze H, Vieta E, Goodwin G et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the treatment of acute mania. World J. Biol. Psychiatry 10, 85-116 (2009).
-
(2009)
World J. Biol. Psychiatry
, vol.10
, pp. 85-116
-
-
Grunze, H.1
Vieta, E.2
Goodwin, G.3
-
24
-
-
77649207564
-
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression
-
Grunze H, Vieta E, Goodwin G et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J. Biol. Psychiatry 11, 81-109 (2010).
-
(2010)
World J. Biol. Psychiatry
, vol.11
, pp. 81-109
-
-
Grunze, H.1
Vieta, E.2
Goodwin, G.3
-
25
-
-
78651023893
-
Lithium salts in the treatment of psychotic excitement
-
Cade JF. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 2(10), 349-352 (1949).
-
(1949)
Med. J. Aust.
, vol.2
, Issue.10
, pp. 349-352
-
-
Cade, J.F.1
-
27
-
-
0033924272
-
In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium
-
Kilts CD. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium. J. Clin. Psychiatry 61(Suppl. 9), 41-46 (2000).
-
(2000)
J. Clin. Psychiatry
, vol.61
, Issue.SUPPL. 9
, pp. 41-46
-
-
Kilts, C.D.1
-
29
-
-
0028173473
-
24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy
-
Plenge P, Stensgaard A, Jensen HV, Thomsen C, Mellerup ET, Henriksen O. 24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy. Biol. Psychiatry 36(8), 511-516 (1994).
-
(1994)
Biol. Psychiatry
, vol.36
, Issue.8
, pp. 511-516
-
-
Plenge, P.1
Stensgaard, A.2
Jensen, H.V.3
Thomsen, C.4
Mellerup, E.T.5
Henriksen, O.6
-
31
-
-
0024341795
-
Neural and developmental actions of lithium: A unifying hypothesis
-
Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59(3), 411-419 (1989).
-
(1989)
Cell
, vol.59
, Issue.3
, pp. 411-419
-
-
Berridge, M.J.1
Downes, C.P.2
Hanley, M.R.3
-
32
-
-
0029776032
-
A molecular mechanism for the effect of lithium on development
-
Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA 93(16), 8455-8459 (1996).
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, Issue.16
, pp. 8455-8459
-
-
Klein, P.S.1
Melton, D.A.2
-
34
-
-
38949167104
-
A systematic review of existing data on long-term lithium therapy: Neuroprotective or neurotoxic?
-
Fountoulakis KN, Vieta E, Bouras C et al. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? Int. J. Neuropsychopharmacol. 11(2), 269-287 (2008).
-
(2008)
Int. J. Neuropsychopharmacol.
, vol.11
, Issue.2
, pp. 269-287
-
-
Fountoulakis, K.N.1
Vieta, E.2
Bouras, C.3
-
35
-
-
0026567408
-
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus
-
Lenox RH, Watson DG, Patel J, Ellis J. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res. 570(1-2), 333-340 (1992).
-
(1992)
Brain Res.
, vol.570
, Issue.1-2
, pp. 333-340
-
-
Lenox, R.H.1
Watson, D.G.2
Patel, J.3
Ellis, J.4
-
36
-
-
0023004543
-
Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts
-
Berrettini WH, Nurnberger JI Jr, Narrow W, Simmons-Alling S, Gershon ES. Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts. Ann. NY Acad. Sci. 487, 197-201 (1986).
-
(1986)
Ann. NY Acad. Sci.
, vol.487
, pp. 197-201
-
-
Berrettini, W.H.1
Nurnberger Jr., J.I.2
Narrow, W.3
Simmons-Alling, S.4
Gershon, E.S.5
-
37
-
-
13344287029
-
Ion homeostasis and the mechanism of action of lithium
-
El-Mallakh RS. Ion homeostasis and the mechanism of action of lithium. Clin. Neurosci. Res. 4(3-4), 227-231 (2004).
-
(2004)
Clin. Neurosci. Res.
, vol.4
, Issue.3-4
, pp. 227-231
-
-
El-Mallakh, R.S.1
-
38
-
-
66049113360
-
Glutamate-mediated calcium signaling: A potential target for lithium action
-
Sourial-Bassillious N, Rydelius PA, Aperia A, Aizman O. Glutamate-mediated calcium signaling: a potential target for lithium action. Neuroscience 161(4), 1126-1134 (2009).
-
(2009)
Neuroscience
, vol.161
, Issue.4
, pp. 1126-1134
-
-
Sourial-Bassillious, N.1
Rydelius, P.A.2
Aperia, A.3
Aizman, O.4
-
39
-
-
0032493304
-
Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex
-
Dixon JF, Hokin LE. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc. Natl Acad. Sci. USA 95(14), 8363-8368 (1998).
-
(1998)
Proc. Natl Acad. Sci. USA
, vol.95
, Issue.14
, pp. 8363-8368
-
-
Dixon, J.F.1
Hokin, L.E.2
-
40
-
-
77449095540
-
Mood-stabilizers target the brain arachidonic acid cascade
-
Rao JS, Rapoport SI. Mood-stabilizers target the brain arachidonic acid cascade. Curr. Mol. Pharmacol. 2(2), 207-214 (2009).
-
(2009)
Curr. Mol. Pharmacol.
, vol.2
, Issue.2
, pp. 207-214
-
-
Rao, J.S.1
Rapoport, S.I.2
-
41
-
-
79953043445
-
Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients
-
DOI: 10.1038/mp.2009.137 Epub ahead of print
-
Kim HW, Rapoport SI, Rao JS. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol. Psychiatry DOI: 10.1038/ mp.2009.137 (2009) (Epub ahead of print).
-
(2009)
Mol. Psychiatry
-
-
Kim, H.W.1
Rapoport, S.I.2
Rao, J.S.3
-
42
-
-
0021745326
-
Lithium intoxication associated with acute renal failure
-
Fenves AZ, Emmett M, White MG. Lithium intoxication associated with acute renal failure. South Med. J. 77(11), 1472-1474 (1984).
-
(1984)
South Med. J.
, vol.77
, Issue.11
, pp. 1472-1474
-
-
Fenves, A.Z.1
Emmett, M.2
White, M.G.3
-
43
-
-
0027942729
-
Lithium-and carbamazepine-associated sinus node dysfunction: Nine-year experience in a psychiatric hospital
-
Steckler TL. Lithium-and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital. J. Clin. Psychopharmacol. 14(5), 336-339 (1994).
-
(1994)
J. Clin. Psychopharmacol.
, vol.14
, Issue.5
, pp. 336-339
-
-
Steckler, T.L.1
-
44
-
-
0020070498
-
Cardiac effects of lithium therapy in man: A review
-
Mitchell JE, Mackenzie TB. Cardiac effects of lithium therapy in man: a review. J. Clin. Psychiatry 43(2), 47-51 (1982).
-
(1982)
J. Clin. Psychiatry
, vol.43
, Issue.2
, pp. 47-51
-
-
Mitchell, J.E.1
MacKenzie, T.B.2
-
45
-
-
0029864621
-
Lithium induced polyuria and renal vasopressin receptor density
-
Hensen J, Haenelt M, Gross P. Lithium induced polyuria and renal vasopressin receptor density. Nephrol. Dial. Transplant. 11(4), 622-627 (1996).
-
(1996)
Nephrol. Dial. Transplant.
, vol.11
, Issue.4
, pp. 622-627
-
-
Hensen, J.1
Haenelt, M.2
Gross, P.3
-
46
-
-
0033012920
-
Lithium and the kidney: An updated review
-
Gitlin M. Lithium and the kidney: an updated review. Drug Saf. 20, 231-243 (1999).
-
(1999)
Drug Saf.
, vol.20
, pp. 231-243
-
-
Gitlin, M.1
-
47
-
-
77449135723
-
Chronic renal complications induced by lithium
-
Le Roy V, Delmas Y, Verdoux H. Chronic renal complications induced by lithium. Encephale 35(6), 605-610 (2009).
-
(2009)
Encephale
, vol.35
, Issue.6
, pp. 605-610
-
-
Le Roy, V.1
Delmas, Y.2
Verdoux, H.3
-
49
-
-
0033042398
-
Effect of lithium mainteinance therapy on thyroid and parathyroid function
-
Kusalic M, Engelsmann F. Effect of lithium mainteinance therapy on thyroid and parathyroid function. J. Psychiatry Neurosci. 24, 227-233 (1999).
-
(1999)
J. Psychiatry Neurosci.
, vol.24
, pp. 227-233
-
-
Kusalic, M.1
Engelsmann, F.2
-
50
-
-
84942476510
-
A reevaluation of risk of in utero exposure to Lithium
-
DOI 10.1001/jama.271.2.146
-
Cohen LS, Friedman J, Jefferson JW, Johnson EM, Weiner ML. A re-evaluation of risk of in utero esposure to lithium. JAMA 271, 146-150 (1994). (Pubitemid 24020593)
-
(1994)
Journal of the American Medical Association
, vol.271
, Issue.2
, pp. 146-150
-
-
Cohen, L.S.1
Friedman, J.M.2
Jefferson, J.W.3
Johnson, E.M.4
Weiner, M.L.5
-
51
-
-
0016162895
-
Ebsteins anomaly and other congenital heart defects
-
Nora JJ, Nora AH, Toews WH. Ebsteins anomaly and other congenital heart defects. Lancet 2, 594-595 (1974).
-
(1974)
Lancet
, vol.2
, pp. 594-595
-
-
Nora, J.J.1
Nora, A.H.2
Toews, W.H.3
-
52
-
-
36348946863
-
Psychotropic medication during pregnancy and lactation
-
Menon SJ. Psychotropic medication during pregnancy and lactation. Arch. Gynecol. Obstet. 277, 1-13 (2008).
-
(2008)
Arch. Gynecol. Obstet.
, vol.277
, pp. 1-13
-
-
Menon, S.J.1
-
53
-
-
0020516123
-
Lithium and pregnancy: A cohort study on manic depressive women
-
Kallen B, Tandberg A. Lithium and pregnancy: a cohort study on manic depressive women. Acta Psychiatrica 68, 134-139 (1983).
-
(1983)
Acta Psychiatrica
, vol.68
, pp. 134-139
-
-
Kallen, B.1
Tandberg, A.2
-
54
-
-
0017096522
-
What happenen later to the lithium babies? A follow-up study of children born without malformations
-
Schou M. What happenen later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr. Scand. 54, 193-197 (1976).
-
(1976)
Acta Psychiatr. Scand.
, vol.54
, pp. 193-197
-
-
Schou, M.1
-
55
-
-
0035989574
-
Managing bipolar disorder during pregnancy: Weighing the risks and benefits
-
Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can. J. Psychiatry 47, 426-436 (2002).
-
(2002)
Can. J. Psychiatry
, vol.47
, pp. 426-436
-
-
Viguera, A.C.1
Cohen, L.S.2
Baldessarini, R.J.3
Nonacs, R.4
-
56
-
-
66249149030
-
Lithium: Updated human knowledge using an evidence-based approach: Part III: Clinical safety
-
Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS Drugs 23(5), 397-418 (2009).
-
(2009)
CNS Drugs
, vol.23
, Issue.5
, pp. 397-418
-
-
Grandjean, E.M.1
Aubry, J.M.2
-
57
-
-
0029903292
-
Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium
-
Granneman GR, Schneck DW, Cavanaugh JH, Witt GF. Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium. J. Clin. Psychiatry 57(5), 204-206 (1996).
-
(1996)
J. Clin. Psychiatry
, vol.57
, Issue.5
, pp. 204-206
-
-
Granneman, G.R.1
Schneck, D.W.2
Cavanaugh, J.H.3
Witt, G.F.4
-
58
-
-
0021682578
-
Lithium-carbamazepine neurotoxicity and risk factors
-
Shukla S, Godwin CD, Long LE, Miller MG. Lithium-carbamazepine neurotoxicity and risk factors. Am. J. Psychiatry 141(12), 1604-1606 (1984).
-
(1984)
Am. J. Psychiatry
, vol.141
, Issue.12
, pp. 1604-1606
-
-
Shukla, S.1
Godwin, C.D.2
Long, L.E.3
Miller, M.G.4
-
59
-
-
0028894053
-
Serotonergic syndrome in combination therapy with lithium and fluoxetine
-
Karle J, Bjrndal F. Serotonergic syndrome in combination therapy with lithium and fluoxetine. Ugeskr. Laeger. 157(9), 1204-1205 (1995).
-
(1995)
Ugeskr. Laeger.
, vol.157
, Issue.9
, pp. 1204-1205
-
-
Karle, J.1
Bjrndal, F.2
-
60
-
-
0030919795
-
Serotonin syndrome after lithium add-on medication to paroxetine
-
Sobanski T, Bagli M, Laux G, Rao ML. Serotonin syndrome after lithium add-on medication to paroxetine. Pharmacopsychiatry 30(3), 106-107 (1997).
-
(1997)
Pharmacopsychiatry
, vol.30
, Issue.3
, pp. 106-107
-
-
Sobanski, T.1
Bagli, M.2
Laux, G.3
Rao, M.L.4
-
61
-
-
0031455648
-
A case of serotonin syndrome caused by venlafaxine and lithium
-
Mekler G, Woggon B. A case of serotonin syndrome caused by venlafaxine and lithium. Pharmacopsychiatry 30(6), 272-273 (1997).
-
(1997)
Pharmacopsychiatry
, vol.30
, Issue.6
, pp. 272-273
-
-
Mekler, G.1
Woggon, B.2
-
62
-
-
0027144398
-
Serotonin syndrome induced by fluvoxamine-lithium interaction [3]
-
Ohman R, Spigset O. Serotonin syndrome induced by fluvoxamine-lithium interaction. Pharmacopsychiatry 26(6), 263-264 (1993). (Pubitemid 24010260)
-
(1993)
Pharmacopsychiatry
, vol.26
, Issue.6
, pp. 263-264
-
-
Ohman, R.1
Spigset, O.2
-
63
-
-
0030062506
-
Lithium and angiotensin-converting enzyme inhibitors: Evaluation of a potential interaction
-
Finley PR, OBrien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J. Clin. Psychopharmacol. 16(1), 68-71 (1996).
-
(1996)
J. Clin. Psychopharmacol.
, vol.16
, Issue.1
, pp. 68-71
-
-
Finley, P.R.1
Obrien, J.G.2
Coleman, R.W.3
-
64
-
-
70849100305
-
Lithium and antihypertensive medication: A potentially dangerous interaction
-
Handler J. Lithium and antihypertensive medication: a potentially dangerous interaction. J. Clin. Hypertens. 11(12) (2009).
-
(2009)
J. Clin. Hypertens.
, vol.11
, Issue.12
-
-
Handler, J.1
-
65
-
-
77950819930
-
Anticonvulsants in bipolar disorder
-
Grunze HC. Anticonvulsants in bipolar disorder. Ment. Health 19(2), 127-141 (2010).
-
(2010)
Ment. Health
, vol.19
, Issue.2
, pp. 127-141
-
-
Grunze, H.C.1
-
66
-
-
0016424327
-
Dipropylacetamide in the treatment of manic-depressive psychosis
-
Lambert PA, Carraz G, Borselli S et al. Dipropylacetamide in the treatment of manic-depressive psychosis. Encephale 1(1), 25-31 (1975).
-
(1975)
Encephale
, vol.1
, Issue.1
, pp. 25-31
-
-
Lambert, P.A.1
Carraz, G.2
Borselli, S.3
-
67
-
-
4243196940
-
Emerging experimental therapeutics for bipolar disorder: Insights from the molecular and cellular actions of current mood stabilizers
-
Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol. Psychiatry 9(8), 734-755 (2004).
-
(2004)
Mol. Psychiatry
, vol.9
, Issue.8
, pp. 734-755
-
-
Gould, T.D.1
Quiroz, J.A.2
Singh, J.3
Zarate, C.A.4
Manji, H.K.5
-
68
-
-
0003495102
-
-
(11th Edition), McGraw-Hill, NY, USA
-
Hardman JG, Limbird LE, Molinoff PB, Ruddon RW (Eds). Goodman & Gilmans The Pharmacological Basis of Therapeutics (11th Edition), McGraw-Hill, NY, USA (2006).
-
(2006)
Goodman & Gilmans the Pharmacological Basis of Therapeutics
-
-
Hardman, J.G.1
Limbird, L.E.2
Molinoff, P.B.3
Ruddon, R.W.4
-
69
-
-
0033926889
-
Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis
-
Ueda Y, Willmore LJ. Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis. Exp. Brain Res. 133(3), 334-339 (2000).
-
(2000)
Exp. Brain Res.
, vol.133
, Issue.3
, pp. 334-339
-
-
Ueda, Y.1
Willmore, L.J.2
-
70
-
-
4344600690
-
Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: Valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels
-
Stahl SM. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels. J. Clin. Psychiatry 65(6), 738-739 (2004).
-
(2004)
J. Clin. Psychiatry
, vol.65
, Issue.6
, pp. 738-739
-
-
Stahl, S.M.1
-
71
-
-
70350161413
-
PtdIns(3,4,5) P(3) and inositol depletion as a cellular target of mood stabilizers
-
Teo R, King J, Dalton E, Ryves J, Williams RS, Harwood AJ. PtdIns(3,4,5) P(3) and inositol depletion as a cellular target of mood stabilizers. Biochem. Soc. Trans. 37(Pt 5), 1110-1114 (2009).
-
(2009)
Biochem. Soc. Trans.
, vol.37
, Issue.PART 5
, pp. 1110-1114
-
-
Teo, R.1
King, J.2
Dalton, E.3
Ryves, J.4
Williams, R.S.5
Harwood, A.J.6
-
72
-
-
67649379380
-
A review of valproate in psychiatric practice
-
Haddad PM, Das A, Ashfaq M, Wieck A. A review of valproate in psychiatric practice. Expert Opin. Drug Metab. Toxicol. 5(5), 539-551 (2009).
-
(2009)
Expert Opin. Drug Metab. Toxicol.
, vol.5
, Issue.5
, pp. 539-551
-
-
Haddad, P.M.1
Das, A.2
Ashfaq, M.3
Wieck, A.4
-
73
-
-
37849050187
-
Lipase and total amylase and its isoenzymes as markers of pancreatic injury in patients treated with antiepileptic drugs
-
Hermida Ameijeiras J, Tutor Crespo MJ, Tutor Valcarce CJ. Lipase and total amylase and its isoenzymes as markers of pancreatic injury in patients treated with antiepileptic drugs. Farm. Hosp. 31, 303-306 (2007).
-
(2007)
Farm. Hosp.
, vol.31
, pp. 303-306
-
-
Hermida Ameijeiras, J.1
Tutor Crespo, M.J.2
Tutor Valcarce, C.J.3
-
74
-
-
0031957837
-
A history of investigation on the mood stabilizing effect of carbamazepine in Japan
-
Okuma T, Kishimoto A. A history of investigation on the mood stabilizing effect of carbamazepine in Japan. Psychiatry Clin. Neurosci. 52(1), 3-12 (1998).
-
(1998)
Psychiatry Clin. Neurosci.
, vol.52
, Issue.1
, pp. 3-12
-
-
Okuma, T.1
Kishimoto, A.2
-
75
-
-
0018880191
-
Carbamazepine in manic-depressive illness: A new treatment
-
Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am. J. Psychiatry 137(7), 782-790 (1980).
-
(1980)
Am. J. Psychiatry
, vol.137
, Issue.7
, pp. 782-790
-
-
Ballenger, J.C.1
Post, R.M.2
-
76
-
-
0033854906
-
Antiepileptic drug pharmacokinetics and interactions: Impact on treatment of epilepsy
-
Cloyd JC, Remmel RP. Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy. Pharmacotherapy 20(8 Pt 2), S139-S151 (2000).
-
(2000)
Pharmacotherapy
, vol.20
, Issue.8 PART 2
-
-
Cloyd, J.C.1
Remmel, R.P.2
-
77
-
-
0036239878
-
Carbamazepine augmentation in depressive patients non-responding to citalopram: A pharmacokinetic and clinical pilot study
-
Steinacher L, Vandel P, Zullino DF, Eap CB, Brawand-Amey M, Baumann P. Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study. Eur. Neuropsychopharmacol. 12(3), 255-260 (2002).
-
(2002)
Eur. Neuropsychopharmacol.
, vol.12
, Issue.3
, pp. 255-260
-
-
Steinacher, L.1
Vandel, P.2
Zullino, D.F.3
Eap, C.B.4
Brawand-Amey, M.5
Baumann, P.6
-
78
-
-
32244439673
-
Interactions between antiepileptic and antipsychotic drugs
-
Besag FM, Berry D. Interactions between antiepileptic and antipsychotic drugs. Drug Saf. 29(2), 95-118 (2006).
-
(2006)
Drug Saf.
, vol.29
, Issue.2
, pp. 95-118
-
-
Besag, F.M.1
Berry, D.2
-
79
-
-
33846083794
-
Historical review of carbamazepine for the treatment of bipolar disorder
-
Stoner SC, Nelson LA, Lea JW, Marken PA, Sommi RW, Dahmen MM. Historical review of carbamazepine for the treatment of bipolar disorder. Pharmacotherapy 27(1), 68-88 (2007).
-
(2007)
Pharmacotherapy
, vol.27
, Issue.1
, pp. 68-88
-
-
Stoner, S.C.1
Nelson, L.A.2
Lea, J.W.3
Marken, P.A.4
Sommi, R.W.5
Dahmen, M.M.6
-
80
-
-
70350161408
-
Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
-
Bazinet RP. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder? Biochem. Soc. Trans. 37(Pt 5), 1104-1109 (2009).
-
(2009)
Biochem. Soc. Trans.
, vol.37
, Issue.PART 5
, pp. 1104-1109
-
-
Bazinet, R.P.1
-
81
-
-
66649127822
-
Anticonvulsants in bipolar disorders: Current research and practice and future directions
-
Bowden CL. Anticonvulsants in bipolar disorders: current research and practice and future directions. Bipolar Disord. 11(Suppl. 2), 20-33 (2009).
-
(2009)
Bipolar Disord.
, vol.11
, Issue.SUPPL. 2
, pp. 20-33
-
-
Bowden, C.L.1
-
82
-
-
32344440085
-
Malformation risks of antiepileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register
-
Morrow J, Russell A, Guthrie E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry 77(2), 193-198 (2006).
-
(2006)
J. Neurol. Neurosurg. Psychiatry
, vol.77
, Issue.2
, pp. 193-198
-
-
Morrow, J.1
Russell, A.2
Guthrie, E.3
-
83
-
-
51449096208
-
Efficiency and safety of oxcarbazepine in mood disorders: A naturalistic study exploring the interest of plasma dosages
-
Misdrahi D, Tournier M, Droulout T et al. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages. Eur. Psychiatry 23(6), 409-412 (2008).
-
(2008)
Eur. Psychiatry
, vol.23
, Issue.6
, pp. 409-412
-
-
Misdrahi, D.1
Tournier, M.2
Droulout, T.3
-
84
-
-
0242300756
-
Oxcarbazepine: Clinical experience with hospitalized psychiatric patients
-
Centorrino F, Albert MJ, Berry JM et al. Oxcarbazepine: clinical experience with hospitalized psychiatric patients. Bipolar Disord. 5(5), 370-374 (2003).
-
(2003)
Bipolar Disord.
, vol.5
, Issue.5
, pp. 370-374
-
-
Centorrino, F.1
Albert, M.J.2
Berry, J.M.3
-
85
-
-
1542345446
-
Safety and tolerability of lamotrigine for bipolar disorder
-
Bowden CL, Asnis GM, Ginsberg LD, Bentley B, Leadbetter R, White R. Safety and tolerability of lamotrigine for bipolar disorder. Drug Saf. 27(3), 173-184 (2004).
-
(2004)
Drug Saf.
, vol.27
, Issue.3
, pp. 173-184
-
-
Bowden, C.L.1
Asnis, G.M.2
Ginsberg, L.D.3
Bentley, B.4
Leadbetter, R.5
White, R.6
-
86
-
-
20544438003
-
Antiepileptic drugs in mood-disordered patients
-
Gajwani P, Forsthoff A, Muzina D et al. Antiepileptic drugs in mood-disordered patients. Epilepsia 46(Suppl. 4), 38-44 (2005).
-
(2005)
Epilepsia
, vol.46
, Issue.SUPPL. 4
, pp. 38-44
-
-
Gajwani, P.1
Forsthoff, A.2
Muzina, D.3
-
87
-
-
0031756758
-
Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder
-
Xie X, Hagan RM. Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 38 (3), 119-130 (1998).
-
(1998)
Neuropsychobiology
, vol.38
, Issue.3
, pp. 119-130
-
-
Xie, X.1
Hagan, R.M.2
-
88
-
-
0023475125
-
Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humans
-
Cohen AF, Land GS, Breimer DD et al. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin. Pharmacol. Ther. 42, 535-541 (1987).
-
(1987)
Clin. Pharmacol. Ther.
, vol.42
, pp. 535-541
-
-
Cohen, A.F.1
Land, G.S.2
Breimer, D.D.3
-
89
-
-
0026005583
-
Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy
-
Ramsay RE, Pellock JM, Garnett WR et al. Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy. Epilepsy Res. 10, 191-200 (1991).
-
(1991)
Epilepsy Res.
, vol.10
, pp. 191-200
-
-
Ramsay, R.E.1
Pellock, J.M.2
Garnett, W.R.3
-
90
-
-
0141961508
-
Lamotrigine: A review of its use in bipolar disorder
-
Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Lamotrigine: a review of its use in bipolar disorder. Drugs 63(19), 2029-2050 (2003).
-
(2003)
Drugs
, vol.63
, Issue.19
, pp. 2029-2050
-
-
Goldsmith, D.R.1
Wagstaff, A.J.2
Ibbotson, T.3
Perry, C.M.4
-
91
-
-
0033937779
-
Adverse reactions to new anticonvulsant drugs
-
Wong IC, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Saf. 23(1), 35-56 (2000).
-
(2000)
Drug Saf.
, vol.23
, Issue.1
, pp. 35-56
-
-
Wong, I.C.1
Lhatoo, S.D.2
-
92
-
-
77049289012
-
Study of 300 case histories of psychotic patients treated with chlorpromazine in closed wards since 1952
-
Delay J, Deniker P, Ropert R. Study of 300 case histories of psychotic patients treated with chlorpromazine in closed wards since 1952, Encephale 45(4), 528-535 (1956).
-
(1956)
Encephale
, vol.45
, Issue.4
, pp. 528-535
-
-
Delay, J.1
Deniker, P.2
Ropert, R.3
-
95
-
-
2542572677
-
Pharmacotherapy for bipolar depression: An economic assessment
-
Bowden CL, Krishnan AA. Pharmacotherapy for bipolar depression: an economic assessment. Expert Opin. Pharmacoter. 5(5), 1101-1107 (2004).
-
(2004)
Expert Opin. Pharmacoter.
, vol.5
, Issue.5
, pp. 1101-1107
-
-
Bowden, C.L.1
Krishnan, A.A.2
-
97
-
-
77951798728
-
Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder
-
McIntyre RS. Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder. Expert Rev. Neurother. 10(5), 645-649 (2010).
-
(2010)
Expert Rev. Neurother.
, vol.10
, Issue.5
, pp. 645-649
-
-
McIntyre, R.S.1
-
98
-
-
0028790556
-
First clinical experience with olanzapine (LY 170053): Results of an open-label and dose-ranging study in patients with schizophrenia
-
Baldwin DS, Montgomery SA. First clinical experience with olanzapine (LY 170053): results of an open-label and dose-ranging study in patients with schizophrenia. Int. Clin. Psychopharmacol. 10(4), 239-244 (1995).
-
(1995)
Int. Clin. Psychopharmacol.
, vol.10
, Issue.4
, pp. 239-244
-
-
Baldwin, D.S.1
Montgomery, S.A.2
-
100
-
-
33846283059
-
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
-
Li X, Rosborough KM, Friedman AB, Zhu W, Roth KA. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int. J. Neuropsychopharmacol. 10(1), 7-19 (2007).
-
(2007)
Int. J. Neuropsychopharmacol.
, vol.10
, Issue.1
, pp. 7-19
-
-
Li, X.1
Rosborough, K.M.2
Friedman, A.B.3
Zhu, W.4
Roth, K.A.5
-
101
-
-
0031595586
-
5HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
-
Kapur S, Zipursky RB, Remington G et al. 5HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am. J. Psychiatry 155(7), 921-928 (1998).
-
(1998)
Am. J. Psychiatry
, vol.155
, Issue.7
, pp. 921-928
-
-
Kapur, S.1
Zipursky, R.B.2
Remington, G.3
-
102
-
-
0031030609
-
Disposition and biotransformation of the antipsychotic agent olanzapine in humans
-
Kassahun K, Mattiuz E, Nyhart E et al. Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Drug Metab. Dispos. 25(1), 81-93(1997).
-
(1997)
Drug Metab. Dispos.
, vol.25
, Issue.1
, pp. 81-93
-
-
Kassahun, K.1
Mattiuz, E.2
Nyhart, E.3
-
103
-
-
0032844187
-
Olanzapine. Pharmacokinetik and pharmacodynamic profile
-
Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Olanzapine. Pharmacokinetik and pharmacodynamic profile. Clin. Pharmacokinet. 37(3), 177-193 (1999).
-
(1999)
Clin. Pharmacokinet.
, vol.37
, Issue.3
, pp. 177-193
-
-
Callaghan, J.T.1
Bergstrom, R.F.2
Ptak, L.R.3
Beasley, C.M.4
-
104
-
-
0029983702
-
In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A
-
Ring BJ, Binkley SN, Vandenbranden M, Wrighton SA. In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A. Br. J. Clin. Pharamacol. 41(3), 181-186 (1996).
-
(1996)
Br. J. Clin. Pharamacol.
, vol.41
, Issue.3
, pp. 181-186
-
-
Ring, B.J.1
Binkley, S.N.2
Vandenbranden, M.3
Wrighton, S.A.4
-
105
-
-
0031757721
-
Lack effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men
-
Macias WL, Bergstrom RF, Cerimele BJ, Kassahun K, Tatum DE, Callaghan JT. Lack effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men. Pharmacotherapy 18(6), 1237-1248 (1998).
-
(1998)
Pharmacotherapy
, vol.18
, Issue.6
, pp. 1237-1248
-
-
MacIas, W.L.1
Bergstrom, R.F.2
Cerimele, B.J.3
Kassahun, K.4
Tatum, D.E.5
Callaghan, J.T.6
-
106
-
-
78650318125
-
-
American Diabetes Association Guidelines
-
American Diabetes Association Guidelines. Diabetes Care 32(Suppl.1) (2009).
-
(2009)
Diabetes Care
, vol.32
, Issue.SUPPL. 1
-
-
-
108
-
-
0032937396
-
Quetiapine fumarate (Seroquel®): A new atypical antipsychotic
-
Goldstein J. Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today (Barc.) 35, 193-210 (1999). (Pubitemid 29238943)
-
(1999)
Drugs of Today
, vol.35
, Issue.3
, pp. 193-210
-
-
Goldstein, J.M.1
-
109
-
-
77956100539
-
Real-world data on atypical antipsychotic medication side effects
-
Cascade E, Kalali AH, Mehra S, Meyer JM. Real-world data on atypical antipsychotic medication side effects, Psychiatry (Edgmont.) 7(7), 9-12 (2010).
-
(2010)
Psychiatry (Edgmont.)
, vol.7
, Issue.7
, pp. 9-12
-
-
Cascade, E.1
Kalali, A.H.2
Mehra, S.3
Meyer, J.M.4
-
110
-
-
78650327585
-
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania
-
Copenhagen, Denmark, 14-16 April
-
Cutler A, Datto C, Nordenhem A et al. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania. Presented at: The 8th Annual International Review of Bipolar Disorders Conference. Copenhagen, Denmark, 14-16 April, 2008.
-
(2008)
Presented At: The 8th Annual International Review of Bipolar Disorders Conference
-
-
Cutler, A.1
Datto, C.2
Nordenhem, A.3
-
111
-
-
77649216935
-
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
-
Copenhagen, Denmark, 14-16 April
-
Suppes T, Datto C, Minkwitz M, Nordenhem A, Walker C, Darko D. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. Presented at: The 8th Annual International Review of Bipolar Disorders Conference. Copenhagen, Denmark, 14-16 April, 2008.
-
(2008)
Presented At: The 8th Annual International Review of Bipolar Disorders Conference
-
-
Suppes, T.1
Datto, C.2
Minkwitz, M.3
Nordenhem, A.4
Walker, C.5
Darko, D.6
-
112
-
-
77950809193
-
Role of extended release quetiapine in the management of bipolar disorders
-
Jurdi RK Al, Dixit LA, Sajatovic M. Role of extended release quetiapine in the management of bipolar disorders. Neuropsychiatr. Dis. Treat. 6, 29-35 (2010).
-
(2010)
Neuropsychiatr. Dis. Treat.
, vol.6
, pp. 29-35
-
-
Al Jurdi, R.K.1
Dixit, L.A.2
Sajatovic, M.3
-
113
-
-
77649134473
-
A double blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)
-
Young AH, Mc Elroy, Bauer M et al. A double blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J. Clin. Psychiatry 71, 150 (2010).
-
(2010)
J. Clin. Psychiatry
, vol.71
, pp. 150
-
-
Young, A.H.1
Elroy, M.2
Bauer, M.3
-
114
-
-
77649138108
-
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)
-
McElroy SL, Weisler RH, Chang W et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J. Clin. Psychiatry 71, 163 (2010).
-
(2010)
J. Clin. Psychiatry
, vol.71
, pp. 163
-
-
McElroy, S.L.1
Weisler, R.H.2
Chang, W.3
-
115
-
-
0028237637
-
Risperidone: A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity
-
Leysen JE, Janssen PM, Megens AA, Schotte A. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J. Clin. Psychiatry 55, 5-12 (1994).
-
(1994)
J. Clin. Psychiatry
, vol.55
, pp. 5-12
-
-
Leysen, J.E.1
Janssen, P.M.2
Megens, A.A.3
Schotte, A.4
-
116
-
-
0029930927
-
Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptors binding
-
Schotte A, Janssen PF, Gommeren W et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptors binding. Psychopharmacology (Berl.) 124(1-2), 57-73 (1996).
-
(1996)
Psychopharmacology (Berl.)
, vol.124
, Issue.1-2
, pp. 57-73
-
-
Schotte, A.1
Janssen, P.F.2
Gommeren, W.3
-
117
-
-
0028361351
-
The pharmacokinetics of risperidone in humans: A summary
-
Heykants J, Huang ML, Mannens G. The pharmacokinetics of risperidone in humans: a summary. J. Clin. Psychiatry 55, 13-17 (1994).
-
(1994)
J. Clin. Psychiatry
, vol.55
, pp. 13-17
-
-
Heykants, J.1
Huang, M.L.2
Mannens, G.3
-
118
-
-
27744476275
-
Intrinsic efficacy of antipsychotics at human D2, D3 and D4 dopamine receptors: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist
-
Burstein ES, Ma J, Wong S et al. Intrinsic efficacy of antipsychotics at human D2, D3 and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. J. Pharmacol. Exp. Ther. 315(3), 1278-1287 (2005).
-
(2005)
J. Pharmacol. Exp. Ther.
, vol.315
, Issue.3
, pp. 1278-1287
-
-
Burstein, E.S.1
Ma, J.2
Wong, S.3
-
119
-
-
0036089687
-
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
-
Burris KD, Molski TF, Xu C et al. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J. Pharmacol. Exp. Ther. 302(1), 381-389 (2002).
-
(2002)
J. Pharmacol. Exp. Ther.
, vol.302
, Issue.1
, pp. 381-389
-
-
Burris, K.D.1
Molski, T.F.2
Xu, C.3
-
120
-
-
0037177358
-
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
-
Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur. J. Pharmacol. 441(3), 137-140 (2002).
-
(2002)
Eur. J. Pharmacol.
, vol.441
, Issue.3
, pp. 137-140
-
-
Jordan, S.1
Koprivica, V.2
Chen, R.3
Tottori, K.4
Kikuchi, T.5
Altar, C.A.6
-
121
-
-
0042887023
-
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
-
Shapiro DA, Renock S, Arrington E. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28(8), 1400-1411(2003).
-
(2003)
Neuropsychopharmacology
, vol.28
, Issue.8
, pp. 1400-1411
-
-
Shapiro, D.A.1
Renock, S.2
Arrington, E.3
-
122
-
-
34249284473
-
Intramuscular aripiprazole in the control of agitation
-
Currier GW, Citrome LL, Zimbroff DL et al. Intramuscular aripiprazole in the control of agitation. J. Psychiatr. Pract. 13(3), 159-169 (2007).
-
(2007)
J. Psychiatr. Pract.
, vol.13
, Issue.3
, pp. 159-169
-
-
Currier, G.W.1
Citrome, L.L.2
Zimbroff, D.L.3
-
123
-
-
21744459699
-
Switching outpatients with bipolar or schizoaffective disorder and substance abuse from their current antipsychotic to aripiprazole
-
Brown ES, Jeffress J, Liggin JD, Garza M, Beard L. Switching outpatients with bipolar or schizoaffective disorder and substance abuse from their current antipsychotic to aripiprazole. J. Clin. Psychiatry 66(6), 756-760 (2005).
-
(2005)
J. Clin. Psychiatry
, vol.66
, Issue.6
, pp. 756-760
-
-
Brown, E.S.1
Jeffress, J.2
Liggin, J.D.3
Garza, M.4
Beard, L.5
-
124
-
-
0036738786
-
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
-
Kane JM, Carson WH, Saha AR et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J. Clin. Psychiatry 63(9), 763-771 (2002).
-
(2002)
J. Clin. Psychiatry
, vol.63
, Issue.9
, pp. 763-771
-
-
Kane, J.M.1
Carson, W.H.2
Saha, A.R.3
-
125
-
-
0038488945
-
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
-
Potkin SG, Saha AR, Kujawa MJ et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch. Gen. Psychiatry 60(7), 681-690 (2003).
-
(2003)
Arch. Gen. Psychiatry
, vol.60
, Issue.7
, pp. 681-690
-
-
Potkin, S.G.1
Saha, A.R.2
Kujawa, M.J.3
-
126
-
-
17844379465
-
Clinical pharmacokinetics of quetiapine: An atypical antipsychotic
-
De Vane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin. Pharmacokinet. 40, 509-522 (2001).
-
(2001)
Clin. Pharmacokinet.
, vol.40
, pp. 509-522
-
-
De Vane, C.L.1
Nemeroff, C.B.2
-
127
-
-
0037311477
-
Synergistic action of 5-HT2A antagonists and selective reuptake inhibitors in neuropsychiatric disorders
-
Marek GJ, Carpenter LL, McDougle CJ, Price LH. Synergistic action of 5-HT2A antagonists and selective reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28(2), 402-412 (2003).
-
(2003)
Neuropsychopharmacology
, vol.28
, Issue.2
, pp. 402-412
-
-
Marek, G.J.1
Carpenter, L.L.2
McDougle, C.J.3
Price, L.H.4
-
128
-
-
28944452691
-
From clinical research to clinical practice: A 4-year review of ziprasidone
-
Nemeroff CB, Lieberman JA, Weiden PJ et al. From clinical research to clinical practice: a 4-year review of ziprasidone. CNS Spectr. 10(11), 1-20 (2005).
-
(2005)
CNS Spectr.
, vol.10
, Issue.11
, pp. 1-20
-
-
Nemeroff, C.B.1
Lieberman, J.A.2
Weiden, P.J.3
-
129
-
-
58649100010
-
Asenapine: A novel psychopharmacologic agent with a unique human receptor signature
-
Shahid M, Walker GB, Zorn SH, Wong EH. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J. Psychopharmacol. 23(1), 65-73 (2009).
-
(2009)
J. Psychopharmacol.
, vol.23
, Issue.1
, pp. 65-73
-
-
Shahid, M.1
Walker, G.B.2
Zorn, S.H.3
Wong, E.H.4
-
130
-
-
66649123127
-
Antipsychotic agents in the treatment of bipolar mania
-
Tohen M, Vieta E. Antipsychotic agents in the treatment of bipolar mania. Bipolar Disord. 11(2), 45-54 (2009).
-
(2009)
Bipolar Disord.
, vol.11
, Issue.2
, pp. 45-54
-
-
Tohen, M.1
Vieta, E.2
-
131
-
-
0031750352
-
Clozapine in bipolar disorder: Treatment implications for other atypical antipsychotics
-
Frye MA, Ketter TA, Altshuler Ll et al. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J. Affect. Disord. 48, 91-104 (1998).
-
(1998)
J. Affect. Disord.
, vol.48
, pp. 91-104
-
-
Frye, M.A.1
Ketter, T.A.2
Ll, A.3
-
133
-
-
12944286545
-
Clozapine in the treatment of refractory psychotic mania
-
Green AI, Tohen M, Patel JK. Clozapine in the treatment of refractory psychotic mania. Am. J. Psichiatry 157, 982-986 (2000).
-
(2000)
Am. J. Psichiatry
, vol.157
, pp. 982-986
-
-
Green, A.I.1
Tohen, M.2
Patel, J.K.3
-
134
-
-
16344363600
-
Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: A case series
-
Macedo-Soares MB, Moreno RA, Rigonatti SP, Lafer B. Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series. J. ECT 21, 31-34 (2005).
-
(2005)
J. ECT
, vol.21
, pp. 31-34
-
-
MacEdo-Soares, M.B.1
Moreno, R.A.2
Rigonatti, S.P.3
Lafer, B.4
-
135
-
-
34547268645
-
Electroconvulsive therapy in the treatment of bipolar depression
-
Valentí M, Benabarre A, Bernardo M, García-Amador M, Amann B, Vieta E. Electroconvulsive therapy in the treatment of bipolar depression. Actas Esp. Psiquiatr. 35(3), 199-207 (2007).
-
(2007)
Actas Esp. Psiquiatr.
, vol.35
, Issue.3
, pp. 199-207
-
-
Valentí, M.1
Benabarre, A.2
Bernardo, M.3
García-Amador, M.4
Amann, B.5
Vieta, E.6
-
136
-
-
56249131097
-
Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression
-
Hallam KT, Smith DI, Berk M. Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression. J. Affect. Disord. 112, 212-218 (2009).
-
(2009)
J. Affect. Disord.
, vol.112
, pp. 212-218
-
-
Hallam, K.T.1
Smith, D.I.2
Berk, M.3
-
137
-
-
0034890446
-
Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression
-
Ciapparelli A, DellOsso L, Tundo A et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J. Clin. Psychiatry 62(7), 552-555 (2001).
-
(2001)
J. Clin. Psychiatry
, vol.62
, Issue.7
, pp. 552-555
-
-
Ciapparelli, A.1
Dellosso, L.2
Tundo, A.3
-
138
-
-
16844368044
-
Treatment guidelines for bipolar disorder: A critical review
-
DOI 10.1016/j.jad.2005.01.004
-
Fountoulakis KN, Vieta E, Sanchez-Moreno J et al. Treatment guidelines for bipolar disorder: a critical review. J. Affect. Disord. 86, 1-10 (2005). (Pubitemid 40487954)
-
(2005)
Journal of Affective Disorders
, vol.86
, Issue.1
, pp. 1-10
-
-
Fountoulakis, K.N.1
Vieta, E.2
Sanchez-Moreno, J.3
Kaprinis, S.G.4
Goikolea, J.M.5
Kaprinis, G.S.6
-
139
-
-
0033863937
-
Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The Olanzapine HGGW Study Group
-
Tohen M, Jacobs TG, Grundy SL et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch. Gen. Psychiatry 57(9), 841-849 (2000).
-
(2000)
Arch. Gen. Psychiatry
, vol.57
, Issue.9
, pp. 841-849
-
-
Tohen, M.1
Jacobs, T.G.2
Grundy, S.L.3
-
141
-
-
0034974809
-
Lithium revisited
-
McIntyre RS, Mancini DA, Parikh S, Kennedy SH. Lithium revisited. Can. J. Psychiatry 46(4), 322-327 (2001).
-
(2001)
Can. J. Psychiatry
, vol.46
, Issue.4
, pp. 322-327
-
-
McIntyre, R.S.1
Mancini, D.A.2
Parikh, S.3
Kennedy, S.H.4
-
142
-
-
0036307574
-
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety
-
Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am. J. Psychiatry 159(7), 1146-1154 (2002).
-
(2002)
Am. J. Psychiatry
, vol.159
, Issue.7
, pp. 1146-1154
-
-
Sachs, G.S.1
Grossman, F.2
Ghaemi, S.N.3
Okamoto, A.4
Bowden, C.L.5
-
143
-
-
0038102784
-
Risperidone in acute and continuation treatment of mania
-
RIS-CAN 25 Study Group
-
Yatham LN, Binder C, Riccardelli R, Leblanc J, Connolly M, Kusumakar V; RIS-CAN 25 Study Group. Risperidone in acute and continuation treatment of mania. Int. Clin. Psychopharmacol. 18(4), 227-235 (2003).
-
(2003)
Int. Clin. Psychopharmacol.
, vol.18
, Issue.4
, pp. 227-235
-
-
Yatham, L.N.1
Binder, C.2
Riccardelli, R.3
Leblanc, J.4
Connolly, M.5
Kusumakar, V.6
-
144
-
-
0037707550
-
Long-term symptomatic status of bipolar i vs. bipolar II disorders
-
Judd LL, Schettler PJ, Akiskal HS et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int. J. Neuropsychopharmacol. 6(2), 127-137 (2003).
-
(2003)
Int. J. Neuropsychopharmacol.
, vol.6
, Issue.2
, pp. 127-137
-
-
Judd, L.L.1
Schettler, P.J.2
Akiskal, H.S.3
-
145
-
-
34547623406
-
Three times more days depressed than manic or hypomanic in both bipolar i and bipolar II disorder
-
Kupka RW, Altshuler LL, Nolen WA et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord. 9, 531-535 (2007).
-
(2007)
Bipolar Disord.
, vol.9
, pp. 531-535
-
-
Kupka, R.W.1
Altshuler, L.L.2
Nolen, W.A.3
-
146
-
-
77951060908
-
Bipolar depression: Overview and commentary
-
Baldessarini RJ, Vieta E, Calabrese JR, Tohen M, Bowden CL. Bipolar depression: overview and commentary. Harv. Rev. Psychiatry 18(3), 143-157 (2010).
-
(2010)
Harv. Rev. Psychiatry
, vol.18
, Issue.3
, pp. 143-157
-
-
Baldessarini, R.J.1
Vieta, E.2
Calabrese, J.R.3
Tohen, M.4
Bowden, C.L.5
-
147
-
-
0034666050
-
Models of bipolar disease and their clinical implications
-
Kupfer DJ. Models of bipolar disease and their clinical implications. Biol. Psychiatry 48(6), 428-429 (2000).
-
(2000)
Biol. Psychiatry
, vol.48
, Issue.6
, pp. 428-429
-
-
Kupfer, D.J.1
-
148
-
-
0036270011
-
The long-term natural history of the weekly symptomatic status of bipolar i disorder
-
Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry 59(6), 530-537 (2002).
-
(2002)
Arch. Gen. Psychiatry
, vol.59
, Issue.6
, pp. 530-537
-
-
Judd, L.L.1
Akiskal, H.S.2
Schettler, P.J.3
-
149
-
-
0032876736
-
Bipolar II disorder and suicidal behavior
-
Rihmer Z, Pestality P. Bipolar II disorder and suicidal behavior. Psychiatr. Clin. North Am. 22(3), 667-673 (1999).
-
(1999)
Psychiatr. Clin. North Am.
, vol.22
, Issue.3
, pp. 667-673
-
-
Rihmer, Z.1
Pestality, P.2
-
150
-
-
33845421095
-
Atypical antipsychotics in the treatment of mood disorders
-
Jarema M. Atypical antipsychotics in the treatment of mood disorders. Curr. Opin. Psychiatry 20(1), 23-29 (2007).
-
(2007)
Curr. Opin. Psychiatry
, vol.20
, Issue.1
, pp. 23-29
-
-
Jarema, M.1
-
151
-
-
47749129275
-
Quetiapine and classical mood stabilizer in the long-term treatment of bipolar disorder: A 4 years follow-up naturalistic study
-
Altamura AC, Mundo E, Dellosso B, Tacchini G, Buoli M, Calabrese JR. Quetiapine and classical mood stabilizer in the long-term treatment of bipolar disorder: a 4 years follow-up naturalistic study. J. Affect. Disord. 110(1-2), 135-141 (2008).
-
(2008)
J. Affect. Disord.
, vol.110
, Issue.1-2
, pp. 135-141
-
-
Altamura, A.C.1
Mundo, E.2
Dellosso, B.3
Tacchini, G.4
Buoli, M.5
Calabrese, J.R.6
-
152
-
-
75549086963
-
Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients
-
Tondo L, Baldessarini RJ. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol. Psichiatr. Soc. 18(3), 179-183 (2009).
-
(2009)
Epidemiol. Psichiatr. Soc.
, vol.18
, Issue.3
, pp. 179-183
-
-
Tondo, L.1
Baldessarini, R.J.2
-
153
-
-
77951968835
-
Lithium reduces pathological aggression and suicidality: A mini-review
-
Muller-Oelinghausen B, Lewitzka U. Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology 62(1), 43-49 (2010).
-
(2010)
Neuropsychobiology
, vol.62
, Issue.1
, pp. 43-49
-
-
Muller-Oelinghausen, B.1
Lewitzka, U.2
-
154
-
-
54349103020
-
Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: Fact or overinterpretation?
-
Grunze HC. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectr. 13(9), 790-795 (2008).
-
(2008)
CNS Spectr.
, vol.13
, Issue.9
, pp. 790-795
-
-
Grunze, H.C.1
-
155
-
-
77954230593
-
Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: A randomized, double-blind, placebo-substitution study
-
Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am. J. Psychiatry 167(7), 792-800 (2010).
-
(2010)
Am. J. Psychiatry
, vol.167
, Issue.7
, pp. 792-800
-
-
Amsterdam, J.D.1
Shults, J.2
-
156
-
-
76449086363
-
Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy
-
Amsterdam JD, Wang G, Shults J. Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy. Acta Psychiatr. Scand. 121(3), 201-208 (2010).
-
(2010)
Acta Psychiatr. Scand.
, vol.121
, Issue.3
, pp. 201-208
-
-
Amsterdam, J.D.1
Wang, G.2
Shults, J.3
-
157
-
-
77952409605
-
Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode
-
Amsterdam JD, Shults J. Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode. J. Clin. Psychopharmacol. 30(3), 306-311 (2010).
-
(2010)
J. Clin. Psychopharmacol.
, vol.30
, Issue.3
, pp. 306-311
-
-
Amsterdam, J.D.1
Shults, J.2
-
158
-
-
0029806545
-
Novel antipsychotics and the problem of clinical stabilization in schizophrenia: Are they stabilizer rather than typical compounds?
-
Altamura AC. Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they stabilizer rather than typical compounds? Int. Clin. Psychopharmacol. 11(3), 153-155 (1996).
-
(1996)
Int. Clin. Psychopharmacol.
, vol.11
, Issue.3
, pp. 153-155
-
-
Altamura, A.C.1
-
159
-
-
77952992661
-
From the concept of antipsychotic to that of multidimensional normostabilizer: The clinical-therapeutic itinerary of schizophrenia
-
Altamura AC. From the concept of antipsychotic to that of multidimensional normostabilizer: the clinical-therapeutic itinerary of schizophrenia. Giorn. Ital. Psicopat. 16, 87-103 (2010).
-
(2010)
Giorn. Ital. Psicopat.
, vol.16
, pp. 87-103
-
-
Altamura, A.C.1
-
160
-
-
77957852355
-
Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder
-
Post RM, Altshuler LL, Frye MA et al. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J. Clin. Psychiatry 71(9), 1176-1186 (2010).
-
(2010)
J. Clin. Psychiatry
, vol.71
, Issue.9
, pp. 1176-1186
-
-
Post, R.M.1
Altshuler, L.L.2
Frye, M.A.3
|